Symptomtext
a patient was administered Menactra that had expired /no AE; Initial information received on 26-Oct-2021 regarding an unsolicited valid non-serious case received from other healthcare professional and consumer/non-healthcare professional via call center via Medical Information (MI) (Reference number- 00829553). This case involves a 13-year-old male patient who received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] that had expired (expired product administered). The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided. Concomitant medications included HEPATITIS A VACCINE, HPV VACCINE VLP RL1 9V (YEAST), and DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR 5-COMPONENT, TETANUS VACCINE TOXOID (ADACEL) for Prophylactic vaccination. On 26-Oct-2021, the patient received a 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number: U6691AA and expiry date: 21-Oct-2021) via an unknown route in the right deltoid for prophylactic vaccination. It was an actual medication error case due to expired vaccine used (latency: same day). It was reported "Nurse is looking for information that they should inform to the patient, as well as if they need to re-vaccinate." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.